Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Interest Payable, Current

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Interest Payable, Current

VISTAGEN THERAPEUTICS, INC. (VTGN) had Interest Payable, Current of $0 as of 2016-12-31, per its 10-Q filed 2017-02-13.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:InterestPayableCurrent · last filed 2017-02-13

  • 2016-12-31: Interest Payable, Current $0.00.
  • 2016-06-30: Interest Payable, Current $0.00.
  • 2016-03-31: Interest Payable, Current $12.00K.
  • 2015-03-31: Interest Payable, Current -$260.70K.
Period endInterest Payable, Current
2016-12-31$0.00
10-Q · filed 2017-02-13
2016-06-30$0.00
10-Q · filed 2016-08-12
2016-03-31$12.00K
10-Q · filed 2017-02-13
2015-03-31-$260.70K
10-K · filed 2016-06-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B